Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vascace 2.5mg tablets
0205051E0BBADAD
|
Vascace | Cilazapril | Cardiovascular System | No data available |
|
Vascace 500microgram tablets
0205051E0BBABAB
|
Vascace | Cilazapril | Cardiovascular System | No data available |
|
Vascace 5mg tablets
0205051E0BBAEAE
|
Vascace | Cilazapril | Cardiovascular System | No data available |
|
Vascalpha 10mg modified-release tablets (Almus)
0206020F0BIADAC
|
Vascalpha | Felodipine | Cardiovascular System | No data available |
|
Vasoxine 20mg/1ml solution for injection ampoules
0207020N0BBAAAA
|
Vasoxine | Methoxamine hydrochloride | Cardiovascular System | No data available |
|
Vastarel 20mg tablets
0206020B0BBAAAA
|
Vastarel | Trimetazidine hydrochloride | Cardiovascular System | No data available |
|
Veletri 1.5mg powder for solution for infusion vials
0208010E0BCABAD
|
Veletri | Epoprostenol sodium | Cardiovascular System | No data available |
|
Veletri 500microgram powder for solution for infusion vials
0208010E0BCAAAC
|
Veletri | Epoprostenol sodium | Cardiovascular System | No data available |
|
Ventavis 10micrograms/ml neb soln 1ml ampoules with Breelib
0205010V0BBACAE
|
Ventavis | Iloprost | Cardiovascular System | No data available |
|
Ventavis 20micrograms/ml neb soln 1ml ampoules with Breelib
0205010V0BBADAF
|
Ventavis | Iloprost | Cardiovascular System | No data available |
|
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules
0205010V0BBABAD
|
Ventavis | Iloprost | Cardiovascular System | No data available |
|
Verapamil 10mg/5ml oral liquid
0206020T0AAA3A3
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 120mg/5ml oral liquid
0206020T0AABABA
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 180mg modified-release / Trandolapril 2mg capsules
0205051V0AAAAAA
|
Trandolapril/verapamil hydrochloride | Trandolapril with calcium channel blocker | Cardiovascular System | No data available |
|
Verapamil 180mg modified-release capsules
0206020T0AAAJAJ
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 20mg/5ml oral liquid
0206020T0AAA2A2
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 240mg/5ml oral liquid
0206020T0AABHBH
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 250mg/5ml oral liquid
0206020T0AABFBF
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 30mg/5ml oral liquid
0206020T0AABEBE
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 40mg/5ml oral liquid
0206020T0AAAZAZ
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 45mg/5ml oral liquid
0206020T0AABDBD
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 50mg/5ml oral liquid
0206020T0AABGBG
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 5mg/2ml solution for injection ampoules
0206020T0AAAAAA
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapamil 80mg/5ml oral liquid
0206020T0AAA1A1
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Verapress MR 240mg tablets (Actavis)
0206020T0BHACAH
|
Verapress | Verapamil hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.